Answers are grounded in this paper and cite their sources.
Vulvar squamous cell carcinoma (VSCC) arises after an HPV infection or the mutation of p53 or other driver genes and is treated by mutilating surgery and/or (chemo) radiation, with limited success and high morbidity. In-depth information on the immunological make up of VSCC is pivotal to assess whether immunotherapy may form an alternative treatment.
No takes yet. Share an insight, caveat, or question.
Abdulrahman et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: